ChEMBL v34 compound record for TIRZEPATIDE (CHEMBL4297839): max_phase 4 (approved), first_approval 2022, parenteral, GIP receptor agonist, first-in-class, black-box warning flag
But dehydration worsens nearly every side effect, from nausea to constipation to fatigue
Unfortunately, its levels are often lower than they should be and the factors contributing to it are mostly poor diet and malnutrition, chronic stress, age, toxins, and overall inflammation
The BW^0.8 exponent is consistent with retatrutides own matched-dose arm pairs in Rosenstock 2023 4 mg ID2 at 108.3 kg vs 4 mg ID4 at 93.1 kg (predicted Cav,ss ratio 1.13, observed 1.18, 4.6% error), and 8 mg slow at 98.4 kg vs 8 mg fast at 95.9 kg (predicted 1.02, observed 1.04, 1.5% error)
AOD-9604, or Advanced Obesity Drug 9604, is a peptide fragment derived from human growth hormone